ELIZABETH GARRANT: Open Payments
NPI 1396224275 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 12 payments from 7 companies in 2025. Trend: 2023 $19 · 2024 $146 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 2 | $64 |
| Genentech USA, Inc. | 2 | $53 |
| Legend Biotech USA Inc. | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Incyte Corporation | 1 | $19 |
Products named: Vanflyta, VENCLEXTA, CARVYKTI, TECVAYLI, NIKTIMVO, Enhertu.
Industry payments across DE — which companies pay providers there.
